Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Robot Surg ; 18(1): 345, 2024 Sep 23.
Article in English | MEDLINE | ID: mdl-39311983

ABSTRACT

Gynecologic surgery with minimally invasive method using robotic or laparoscopic techniques has gained popularity for reducing perioperative discomfort and length of hospital stay. However, the debate over postoperative pain superiority between traditional laparoscopy and robotic surgery persist. This study compared the postoperative pain of patients within 24 h of robotic (RM) and laparoscopic myomectomy (LM). This retrospective cohort study included 24 and 53 patients who underwent RM and LM, respectively, between January 2019 and July 2023. The primary outcomes were the postoperative pain levels of patients within 24 h and the use and dosage of postoperative analgesia. Additional perioperative analgesia, including long-acting non-steroidal anti-inflammatory drugs (Dynastat) and abdominal nerve block, was also recorded. The secondary outcomes were blood loss and hospitalization duration. The patient characteristics were similar between the groups. Factors that could potentially increase pain, such as the number of ports (p < 0.0001), additional procedures (p = 0.0195), operative time (p < 0.0001), number of myomas (p = 0.0057), and the largest myoma size (p = 0.0086), were significantly higher in the RM group than in the LM group. However, there were no significantly different in the postoperative visual analog scale pain scores, use and dosage of ketorolac and opioid, and use of Dynastat and nerve block between the groups. Hospitalization duration and intraoperative blood loss were similar between the groups. RM and LM offer comparable postoperative pain outcomes, emphasizing the importance of patient-specific factors in decision-making regarding myomectomy techniques.


Subject(s)
Laparoscopy , Pain, Postoperative , Robotic Surgical Procedures , Uterine Myomectomy , Humans , Robotic Surgical Procedures/methods , Robotic Surgical Procedures/adverse effects , Retrospective Studies , Pain, Postoperative/prevention & control , Pain, Postoperative/etiology , Uterine Myomectomy/methods , Uterine Myomectomy/adverse effects , Female , Laparoscopy/methods , Laparoscopy/adverse effects , Adult , Middle Aged , Uterine Neoplasms/surgery , Cohort Studies , Operative Time , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Pain Measurement , Length of Stay/statistics & numerical data , Analgesics, Opioid/therapeutic use , Analgesics, Opioid/administration & dosage , Leiomyoma/surgery , Blood Loss, Surgical/statistics & numerical data
2.
Medicine (Baltimore) ; 103(29): e39017, 2024 Jul 19.
Article in English | MEDLINE | ID: mdl-39029021

ABSTRACT

RATIONALE: Bacterascites are a rare complication of cesarean sections (C/S). Here, we report the case of a patient with bacterascites after an emergent C/S. PATIENT CONCERN: A 41-year-old female reported diffuse abdominal tightness and pain for a week after C/S, who received C/S at 38 4/7 weeks due to superimposed preeclampsia and prolonged labor. DIAGNOSES: Bacterascites caused by Salmonella species after C/S was diagnosed. INTERVENTIONS: Initial treatment included cefmetazole and metronidazole. On day 2, paracentesis was performed, followed by albumin and hydroxyethyl starch administration. By day 3, the patient developed pulmonary edema, necessitating Lasix administration. On day 6, ascites culture revealed Salmonella species resistant to third-generation cephalosporins, leading to meropenem therapy adjustment. This resulted in improved symptoms. Meropenem was continued for 14 days to complete the treatment regimen. OUTCOMES: Follow-up ultrasonography revealed a decrease in ascites. As the patient clinical condition improved, she was discharged on day 20 and scheduled for outpatient department follow-up. No recurrence of ascites was observed during the subsequent follow-up period of 3 months. No ascites were noted 8 days after discharge. LESSONS: Postoperative bacterascites with Salmonella were diagnosed. Antibiotic treatment and therapeutic paracentesis were effective for this condition.


Subject(s)
Anti-Bacterial Agents , Cesarean Section , Salmonella Infections , Salmonella , Humans , Female , Adult , Cesarean Section/adverse effects , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/administration & dosage , Salmonella/isolation & purification , Salmonella Infections/diagnosis , Salmonella Infections/drug therapy , Pregnancy , Meropenem/therapeutic use , Meropenem/administration & dosage , Ascites/etiology , Ascites/microbiology , Bacteremia/microbiology , Bacteremia/drug therapy , Postoperative Complications/microbiology , Paracentesis/methods
SELECTION OF CITATIONS
SEARCH DETAIL